Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0BVZGV
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Anti-ADAM9 (C442)-DGN549
|
|||||
| Synonyms |
Anti-ADAM9 antibody drug conjugate (ImmunoGen); AEX6003-DGN549
Click to Show/Hide
|
|||||
| Organization |
ImmunoGen, Inc.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 3 Indication(s)
Pancreatic cancer [ICD11:2C10]
Clinical candidate
Prostate cancer [ICD11:2C82]
Clinical candidate
Renal cell carcinoma [ICD11:2C90]
Clinical candidate
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Structure |
|
|||||
| Antibody Name |
AEX6003 (S442C)
|
Antibody Info | ||||
| Antigen Name |
Disintegrin and metalloproteinase domain-containing protein 9 (ADAM9)
|
Antigen Info | ||||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
| Combination Type |
DGN549-L
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.